Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Voss

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Vaccine|December 29, 2010
Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationMartin P Cranage, Carol A Fraser, Alethea Cope, et al.
Journal of Virology|November 14, 2008
Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core proteinAndreas Mörner, Iyadh Douagi, Mattias N E Forsell, et al.
Plos Pathogens|May 30, 2009
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding siteBarna Dey, Krisha Svehla, Ling Xu, et al.
Vaccine|January 27, 2007
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge modelErik Rollman, Nathalie Mathy, Andreas Bråve, et al.
Vaccine|June 21, 2014
Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adultsKent E Kester, D Gray Heppner, Philippe Moris, et al.
Tuberculosis (Edinburgh, Scotland)|December 14, 2020
The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine developmentDanielle Roordink, Ann Williams, Bernard Fritzell, et al.
Vaccine|November 2, 2024
Burden of Lassa fever disease in pregnant women and children and options for preventionManu Chaudhary, Clare L Cutland, Mercedes Bonet, et al.
The American Journal of Tropical Medicine and Hygiene|May 25, 2004
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysDouglas S Walsh, Sathit Pichyangkul, Montip Gettayacamin, et al.
Vaccine|September 15, 2004
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alumSathit Pichyangkul, Montip Gettayacamin, R Scott Miller, et al.
Vaccine|July 19, 2025
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding womenFlor M Munoz, Beate Kampmann, Andy Stergachis, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Vaccine|December 29, 2010
Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationMartin P Cranage, Carol A Fraser, Alethea Cope, et al.
Journal of Virology|November 14, 2008
Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core proteinAndreas Mörner, Iyadh Douagi, Mattias N E Forsell, et al.
Plos Pathogens|May 30, 2009
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding siteBarna Dey, Krisha Svehla, Ling Xu, et al.
Vaccine|January 27, 2007
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge modelErik Rollman, Nathalie Mathy, Andreas Bråve, et al.
Vaccine|June 21, 2014
Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adultsKent E Kester, D Gray Heppner, Philippe Moris, et al.
Tuberculosis (Edinburgh, Scotland)|December 14, 2020
The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine developmentDanielle Roordink, Ann Williams, Bernard Fritzell, et al.
Vaccine|November 2, 2024
Burden of Lassa fever disease in pregnant women and children and options for preventionManu Chaudhary, Clare L Cutland, Mercedes Bonet, et al.
The American Journal of Tropical Medicine and Hygiene|May 25, 2004
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysDouglas S Walsh, Sathit Pichyangkul, Montip Gettayacamin, et al.
Vaccine|September 15, 2004
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alumSathit Pichyangkul, Montip Gettayacamin, R Scott Miller, et al.
Vaccine|July 19, 2025
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding womenFlor M Munoz, Beate Kampmann, Andy Stergachis, et al.
Pageof 5